ArticleThe Journal of biological chemistry2020
The
Open access · hybridAbstract read
In one paragraph
Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 25 citations in OpenAlex.
- Deep learning-enabled scaffolding of spatial arrays of PfCSP epitopes.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- The NMDAR/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer's disease.Molecular psychiatry · 2026Article
- mRNA delivery of circumsporozoite protein epitope-based malaria vaccines induces protection in a mouse model.NPJ vaccines · 2025Article
- Genetic polymorphism of circumsporozoite protein of Plasmodium falciparum isolates in children in Brazzaville, Republic of Congo.Malaria journal · 2025Article
- Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens.NPJ vaccines · 2025Article
- Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.Science (New York, N.Y.) · 2025Article
- Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N-terminal domain.Protein science : a publication of the Protein Society · 2024Article
- ProC6C, a novel multi-stage malaria vaccine, elicits functional antibodies against the minor and central repeats of the Circumsporozoite Protein in human adults.Frontiers in immunology · 2024Article
- Article
- Production and Purification of Plasmodium Circumsporozoite Protein in Lactococcus lactis.Methods in molecular biology (Clifton, N.J.) · 2024Article
- A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments.Vaccines · 2023Review
- Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages.Communications biology · 2022Article
- Probiotics Surface-Delivering Fiber2 Protein of Fowl Adenovirus 4 Stimulate Protective Immunity Against Hepatitis-Hydropericardium Syndrome in Chickens.Frontiers in immunology · 2022Article
- Method for Production of Cysteine-Rich Proteins in Lactococcus lactis Expression System.Methods in molecular biology (Clifton, N.J.) · 2022Article
- Heterologous Expression and Evaluation of NovelFrontiers in immunology · 2022Article
- Oral Immunization With a M Cell-Targeting RecombinantFrontiers in immunology · 2022Article
- Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.NPJ vaccines · 2021Article
- Oral Immunization of RecombinantFrontiers in veterinary science · 2021Article
- A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria.International journal of biological macromolecules · 2020Article
- A Reproducible and Scalable Process for Manufacturing a Pfs48/45 BasedFrontiers in immunology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 4 countries.
Susheel K SinghDepartment for Congenital Disorders, Statens Serum Institut, 2300 Copenhagen, Denmark; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
Jordan PlieskattPATH's Malaria Vaccine Initiative, Washington, D. C. 20001.
Bishwanath Kumar ChourasiaDepartment for Congenital Disorders, Statens Serum Institut, 2300 Copenhagen, Denmark; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
Vandana SinghDepartment for Congenital Disorders, Statens Serum Institut, 2300 Copenhagen, Denmark; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
Judith M BolscherTropIQ Health Sciences, 6534 AT Nijmegen, The Netherlands.
Koen J DecheringTropIQ Health Sciences, 6534 AT Nijmegen, The Netherlands.
Bright AduNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Blanca López-MéndezNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Swarnendu KavirajGennova Biopharmaceuticals Limited, Pune 411057, India.
Emily LockePATH's Malaria Vaccine Initiative, Washington, D. C. 20001.
C Richter KingPATH's Malaria Vaccine Initiative, Washington, D. C. 20001.
Michael TheisenDepartment for Congenital Disorders, Statens Serum Institut, 2300 Copenhagen, Denmark; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark. Electronic address: mth@ssi.dk.
University of Copenhagen · DKU.S. President's Malaria Initiative · USTropIQ Health Sciences · NLNoguchi Memorial Institute for Medical Research · GHStatens Serum Institut · DK
Funding
No grant is acknowledged in the PubMed record.
Abstract
The
Indexed as
AnimalsCell LineFemaleGene ExpressionHumansLactococcus lactisMalaria, FalciparumMalaria VaccinesMicePlasmodium falciparumProtein FoldingProtein StabilityProtozoan ProteinsRecombinant ProteinsSolubilitycircumsporozoite protein, ProtozoanMalaria VaccinesProtozoan ProteinsRecombinant Proteinschromatographycircumsporozoite proteinimmunogenicityLactococcus lactismalariaparasitePlasmodium falciparumprotein expressionprotein foldingvaccine development
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.